Oregon Hospitals Report Reduction in HAIs, Achieve Cost Savings
Oregon hospitals reported a reduction in healthcare-associated infections (HAIs) as well as a potential cost savings as a result of hospitals enhanced infection prevention activities.
Central line-associated bloodstream infections (CLABSIs) in hospital intensive care units (ICUs) have decreased 55 percent from 2009 to 2011, and the estimated healthcare cost savings for this infection ranges from $600,000 to $2.5 million during those years. In addition, Oregon has demonstrated a 10 percent reduction in surgical site infections (SSIs) from coronary artery bypass graft surgeries and a 20 percent reduction in SSIs from knee replacement surgeries since 2009.
The report highlights:
In 2011, Oregon introduced five new HAI measures and four are now below the national average.
- CLABSIs in ICUs (44 percent lower)
- Abdominal hysterectomy SSIs (21 percent lower)
- Colon surgery SSIs (20 percent lower)
- Laminectomy SSIs (31 percent lower)
However, the hip replacement SSI rate was reported to be 13 percent higher than the national average.
Oregon's HAI report can be accessed here: http://www.oregon.gov/oha/OHPR/pages/hai_report.aspx
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
